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A 22 year old woman presented to Queen Elizabeth Central 
Hospital with a three days history of  fever, headache and 
vomiting, with progressive difficulty in swallowing. 
Past history
Two weeks previously, she was admitted to hospital for severe 
anaemia ([Hb] 3.2g/dl) and probable sepsis, for which she 
was transfused three units of  blood and received ceftriaxone 
and ciprofloxacin therapy.  Her HIV test was found to be 
positive on that occasion, and she was commenced on 
cotrimoxazole prophylaxis.  She was advised to start ART as 
soon as possible at her nearest health centre. She had not lost 
consciousness and had not had any convulsions.
On examination for the present re-admission: 
The patient was weak, lethargic and very pale. The temperature 
was 38.6oC, blood pressure 80/40, pulse rate 138/min and 
breathing rate 42/min. Severe oral thrush was noted. Lymph 
nodes were not enlarged. Chest and heart examinations were 
normal.  There was generalized abdominal tenderness and 
the spleen was 10cm palpable. The skin and extremities 
were normal.  There was moderate neck stiffness.  No other 
neurological abnormality was found.  
Ophthalmoscopy revealed severe retinopathy (see Figs 1-3)
Investigations
Full blood count: [Hb] 1.9g/dl, wbc 4.2 x 109/l, (neutrophils 
39%, lymph 39%), platelets 21 x 109/l.  Thin film: red cells 
normocytic; no malaria parasites seen; for additional cells see 
Fig 4.
CD4 count 377/ul.  Random blood glucose 60mg/dl. 
Lumbar puncture: opening pressure 6cm, fluid cloudy and 
slightly blood stained. Microscopy of  CSF: 560 red blood 
cells/ul, glucose 48 mg/dl, protein 97 mg/dl; Indian ink test 
negative for cryptococci.  There was no growth on culture 
after 48 hours of  incubation.  Blood culture: no growth. 
Ultrasonography of  abdomen: mild hepatosplenomegaly, 
normal kidneys, no lymphadenopathy
Treatment and progress
The patient was started on ceftriaxone 2g BD IV, fluconazole 
200mg od and paracetamol.  Five units of  blood were 
transfused.  Cotrimoxazole prophylaxis was continued.  On 
the fourth day the patient had repeated convulsions, which 
were controlled by administration of  phenobarbitone. 
A repeat full blood count 10 days later showed  improvement 
in white cell count to 6.8 x 109/l (neurophils 52% lymph 
33%), and in [Hb] to 5.2 g/dl (MCV 78, MCH 26.9); but 
platelets remained low at 20 x 109/l. 
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Figure 3 Retinal appearances at ophthalmoscopy
Figure 2  Retinal appearances at ophthalmoscopy
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Figure 1 Retinal appearances at ophthalmoscopy
Figure 4
1. Describe the ophthalmoscopic findings (Figs 
1-3).
2. What do the peripheral blood films show (Fig 4)? 
3. What are the likely causes of her problem?
Turn to pg 88 for a discussion of this case.
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The retinal appearances (Figs 1-3) include multiple white-
centred haemorrhages, two large white retinal lesions close 
to the left optic disk, and retinal haemorrhage and fluid just 
nasal to the R fovea.   All of  these changes are non-specific 
but are compatible with a severe systemic disease with 
thrombocytopenia as discussed below.
The peripheral blood film (Fig 4) shows the presence of  
blast cells with intense blue cytoplasm
Discussion
This patient presented with normocytic anaemia in the setting 
of  pancytopenia, as noted on FBC and PBF. Pancytopenia in 
a patient with advanced stage HIV infection and sepsis is not 
uncommon and is often multifactorial especially in a tropical 
setting. Anaemia of  inflammation, peripheral consumption 
due to sepsis itself, nutritional deficiencies, drugs, chronic 
infections such as TB, and the direct effect of  HIV infection 
itself  can all be factors and commonly coexist.  It is entirely 
reasonable in the acute situation to assess response to 
treatment of  sepsis and other identifiable conditions before 
seeking more specific bone marrow pathology.
However, the finding of  blasts in the peripheral blood in 
the context of  severe pancytopenia is almost diagnostic 
of  acute leukaemia.  Further characterization of  an acute 
leukaemia as an acute lymphoid or myeloid leukaemia cannot 
be achieved based on light microscopy alone and requires 
immunophenotyping and/or molecular biology techniques. 
However, blasts with intense blue cytoplasm suggest a B cell 
origin. In the context of  HIV infection, this is suggestive 
of  Burkitt’s lymphoma.  Somewhat confusingly, Burkitt’s 
lymphoma not infrequently presents with a purely leukaemic 
picture; indeed acute lymphoblastic leukaemia subtype L3 
in the FAB classification is recognised to be biologically 
identical to Burkitt’s lymphoma. 
HIV infection is well known to predispose to development 
of  haematological malignancies. The incidence of  true 
acute leukaemias may be slightly increased in HIV infection 
; a twofold higher incidence has been seen in AML in the 
developed world 1 and this is probably similar in Africa.2. 
HIV infection increases the risk of  development of  a 
lymphoma 60 to 165 fold over that of  the HIV seronegative 
population. Approximately 70 to 90 percent of  the 
lymphomas encountered in HIV-infected patients are high 
grade lymphomas, particularly diffuse large B cell (DLBCL) 
and Burkitt’s lymphomas (BL)3. Statistically therefore, an 
HIV positive adult presenting with a leukaemic blood picture 
is likely to have Burkitt’s lymphoma.   DLBCL usually arises 
in those with more advanced HIV infection, with a CD4 
count typically <100 cells/microL, while BL may occur in 
the setting of  a wide range of  CD4 counts.
Burkitt’s lymphoma has long been a disease of  interest in 
sub-Saharan Africa.  The classical form of  the disease is 
prevalent in regions of  Africa where malaria is endemic. 
This is a disease of  children, classically affects the bones of  
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the face or presents as abdominal or CNS tumours, and can 
account for over half  of  childhood malignancies in endemic 
regions 4,5.  It is an aggressive B cell malignancy, and is 
characterised by an 8,14 chromosomal translocation creating 
a fusion gene between the cMYC oncogene and the IGH 
immunoglobulin heavy chain gene. The Epstein-Barr virus 
(EBV) is associated with almost all cases and is considered 
to play a causative role.  In non-malarial areas,  a form of  the 
disease termed sporadic Burkitt’s or Burkitt-like lymphoma 
occurs but is rare in non-immunosuppressed individuals. 
This has a different clinical course, rarely presenting with 
facial disease, but is still thought to be EBV associated.  With 
the advent of  HIV infection in Africa, Burkitt’s lymphoma 
has become more prevalent in adults, but interestingly does 
not tend to follow the clinical course of  the endemic form.6.
Although Burkitt’s-like lymphomas can respond rapidly to 
chemotherapy in the short term, survival is poor in both HIV 
positive and negative patients with conventional intensity 
regimens such as CHOP.  There is commonly rapid relapse, 
in particular within the central nervous system. Two-year 
survivals of  around 50-60% can be achieved with intensive 
chemotherapy regimens incorportating CNS treatment 
such as CODOX-M/IVAC, however such regimens cause 
prolonged neutropenia and need excellent supportive care 
to be able to achieve good outcomes7.  With concomitant 
antiretroviral therapy, outcomes in HIV positive patients in 
the developed world are equivalent or slightly better than in 
HIV negative patients8.   Interestingly, children with endemic 
Burkitt’s can achieve long-term survival with single agent 
chemotherapy9, suggesting that the biology of  endemic 
Burkitt’s may differ substantially from the sporadic disease. 
Extent of disease in our patient
Our patient was noted to have systemic spread with bone 
marrow involvement. The absence of  white blood cells in the 
CSF did not exclude leptomeningeal involvement.   Occult 
CNS involvement is very frequently present in Burkitt’s 
lymphoma, and concentration of  cells in the CSF by cytospin 
is often required to detect this.  It remains possible that the 
seizures in our patient were due to CNS disease.  The raised 
CSF protein and low CSF glucose relative to serum levels is 
compatible with CNS lymphoma.  The recurrent fever may 
be attributed to recurrent bacterial infections to which the 
patient was susceptible because of  neutropenia.  However, 
it is possible that the fever could be due to ‘B’ symptoms of  
the malignancy. 
Treatment and prognosis
The prognosis in this patient would have been poor with 
presentation of  advanced disease (stage 4)  even with optimal 
care facilities.  In a resource poor setting, myelosuppression 
due to marrow infiltration is the limiting factor in considering 
chemotherapy.  Even if  her disease were responsive to the 
lower intensity chemotherapy regimens currently available, 
it would be necessary to provide supportive care for a 
prolonged period of  neutropenia until recovery of  normal 
haematopoiesis.  Nevertheless, non-myelosuppressive agents 
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such as vincristine and steroids (particularly dexamethasone 
in view of  its CNS penetration) may play a useful role as an 
adjunct  to symptomatic care; the disappearance of  blasts 
from the peripheral blood after steroid therapy suggests her 
disease did show a response though this was short-lived.  
The availability of  community palliative care services enabled 
this patient to be discharged home with arrangements for 
ongoing symptomatic care.  Despite the fact that we could 
not give curative treatment, it was beneficial in this patient to 
arrive promptly at a working pathological diagnosis, because 
this allowed us to make a positive decision to concentrate 
our efforts on palliative care.
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The inaugural Malawian science café
On 8th April 2009, the first African science café was launched 
at College of  Medicine Sports Complex Breezer Bar. This is 
an initiative of  the Malawi Wellcome Liverpool Trust (MLW 
and the Malawi Medical Journal (MMJ). Khanyiwe Shawa, 
science communication 
officer (MLW), who was also 
the moderator of  the event, 
introduced science cafés as 
live events where science, 
food and drink make excellent 
conversation. Science cafes 
are the brainchild of  Duncan 
Dallas,UK with the African 
science cafes based on the 
European Cafe Scientifique 
model. They involve face-
to-face interaction between 
the lay public and scientists. 
They offer an opportunity 
for scientists and the public 
to engage with each other 
to discuss current and or 
controversial health, science, 
research and technology topics 
in a relaxed environment. 
Scientist are encouraged to 
talk in plain language and 
the audience is advised to speak  their mind, ask provoking 
questions, meet new friends, and talk with their mouths full.
The theme of  the first science cafe was “ Prevention of  Mother 
to Child Transmission (PMTCT), how does it really happen?”. 
The two speakers Dr. Victor Mwapasa of  the College of  
Medicine and MLW and Dr.George Kafulafula of  the College 
of  Medicine and Johns Hopkins gave very lively presentations 
on how  HIV is transmitted during pregnancy and how it can 
be prevented. They also presented current research findings 
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also served to 
par t ic ipants 
courtesy of  
the Centre for 
Reproductive 
Health, College of  Medicine. Participants at the function 
were from all walks of  life and included nurses, students, and 
engineers.  The science cafe was well received by the public 
with calls for more science cafes on discordant couples, 
malaria and TB. 
